Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role STAT 1d STAT 1d
FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair News-Medical.Net 1d News-Medical.Net 1d
Collplant announces a $3.7 Million private placement PR Newswire (Press Release) 2d PR Newswire (Press Release) 2d
Stuart therapeutics expands pipeline with corneal wound healing program Business Wire (Press Release) 2d Business Wire (Press Release) 2d
Analysts expect breakeven for Capricor Therapeutics, Inc. (NASDAQ:CAPR) before long Simply Wall St 2d Simply Wall St 2d
Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough South China Morning Post 03:17
Genentech Presents New Phase III One-Year Data for Vamikibart in Uveitic Macular Edema (Ume), a Serious Cause of Vision Loss Business Wire (Press Release) 22:46 Sat, 10 Oct
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw The Times of India 19:50 Sat, 10 Oct
n6 expands global distribution footprint, bringing iconPCR™ and AutoNorm to more scientists across Europe, the Middle East, and Africa News-Medical.Net 07:43 Sat, 10 Oct
Me Therapeutics Extends Option Agreement for CD22 Nanobody Asset Business Wire (Press Release) 23:37 Fri, 09 Oct
Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role STAT 22:11 Fri, 09 Oct